Review article

SECONDARY (AA) AMYLOIDOSIS IN CROHN’S DISEASE

TOMISLAV BULUM ; Vuk Vrhovac Clinic for Diabetes, Endocrinology and Metabolic Diseases, Zagreb, Croatia
INGRID PRKAČIN ; University Department of Medicine, Merkur University Hospital, Zagreb,Croatia
GORDANA CAVRIĆ ; University Department of Medicine, Merkur University Hospital, Zagreb,Croatia
NIKOLA SOBOČAN ; University Department of Medicine, Merkur University Hospital, Zagreb,Croatia
BRUNO ŠKURLA ; University Department of Medicine, Merkur University Hospital, Zagreb,Croatia
LEA DUVNJAK ; Vuk Vrhovac Clinic for Diabetes, Endocrinology and Metabolic Diseases, Zagreb, Croatia
STELA BULIMBAŠIĆ ; Department of Pathology, Dubrava University Hospital, Zagreb, Croatia

Abstract

Amyloidosis is a clinical entity that results from deposition of an extracellular protein material that causes disruption in normal architecture and impairs function of multiple organs and tissues. Secondary amyloidosis (AA) is a rare but serious complication that occurs in the context of cancer, chronic inflammation and chronic infectious diseases, including inflammatory bowel disease, mainly long-standing Crohn’s disease. Renal failure is the most common clinical presentation of AA, ranging from nephrotic syndrome and impaired renal function to renal failure, with a potential for high morbidity. The incidence of the association of t. Bulum, i. Prka

Keywords

amyloidosis; Crohn’s disease; nephrotic syndrome

Hrčak ID:

89275

URI

https://hrcak.srce.hr/89275

Publication date:

17.10.2012.

Article data in other languages: croatian

Visits: 3.097 *